Síguenos en Twitter     Síguenos en Facebook     Síguenos en Google+     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Pinterest     Slack     Google Drive     Reddit     StumbleUpon     Print

SOBRE EL AUTOR **

Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com

WORLD EMERGENCY MEDICINE SOCIETIES

Cranial Nerve VI Palsy Emergency

Buscar en contenido

Contenido:

jueves, 28 de mayo de 2015

Sangrado intracraneal

emDocs

emDocs - October 17, 2014 - By Jeremy Kim /  Edited by Koyfman A and Alerhand S

"Take-Home Points
  • Anti-platelet agents are commonly used by patients, particularly those with history of CAD or CVA
  • Aspirin is an irreversible COX-1 inhibitor with ineffective metabolites, leading to short duration of effect. Clopidogrel has active metabolites, leading to a longer duration of effect.
  • Current literature is not conclusive for management/reversal of anti-platelet agents
  • For patients with ICH or highly suspected to have ICH, consider administering:
    • 1-2 single-donor packed platelets and ddAVP (0.3 mcg/kg)
    • Consider further platelet transfusions and ddAVP doses for larger bleeds or for dual anti-platelet therapy"
http://www.emdocs.net/platelets-ddavp-management-intracranial-hemorrhage/